| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18653595 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 126 journal articles in the PubMed database | Email to a friend | | |
| Arias L, Planas N, Prades S, et al.
Intravitreal bevacizumab (Avastin) for choroidal neovascularisation secondary to pathological myopia: 6-month results. [Clinical Trial, Journal Article, Review]
Br J Ophthalmol 2008 Aug; 92(8):1035-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chan WM, Lai TY, Liu DT, et al.
Intravitreal Bevacizumab (Avastin) for Myopic Choroidal Neovascularization Six-Month Results of a Prospective Pilot Study. [JOURNAL ARTICLE]
Ophthalmology 2007 Jun 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yamamoto I, Rogers AH, Reichel E, et al.
Intravitreal Bevacizumab (Avastin) as Treatment for Subfoveal Choroidal Neovascularization Secondary to Pathologic Myopia. [JOURNAL ARTICLE]
Br J Ophthalmol 2006 Jul 26.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Goff MJ, Johnson RN, McDonald HR, et al.
INTRAVITREAL BEVACIZUMAB FOR PREVIOUSLY TREATED CHOROIDAL NEOVASCULARIZATION FROM AGE-RELATED MACULAR DEGENERATION. [JOURNAL ARTICLE]
Retina 2007 April/May; 27(4):432-438.
Abstract | Full Citation | Find Related Articles | | Sakaguchi H, Ikuno Y, Gomi F, et al.
Intravitreal injection of bevacizumab for choroidal neovascularization caused by pathological myopia. [JOURNAL ARTICLE]
Br J Ophthalmol 2006 Aug 16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Chan WM, Lai TY, Liu DT, et al.
Intravitreal Bevacizumab (Avastin) for Choroidal Neovascularization Secondary to Central Serous Chorioretinopathy, Secondary to Punctate Inner Choroidopathy, or of Idiopathic Origin. [JOURNAL ARTICLE]
Am J Ophthalmol 2007 Jun; 143(6):977-983.e1.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Hernández-Rojas ML, Quiroz-Mercado H, Dalma-Weiszhausz J, et al.
SHORT-TERM EFFECTS OF INTRAVITREAL BEVACIZUMAB FOR SUBFOVEAL CHOROIDAL NEOVASCULARIZATION IN PATHOLOGIC MYOPIA. [JOURNAL ARTICLE]
Retina 2007 July/August; 27(6):707-712.
Abstract | Full Citation | | Mandal S, Venkatesh P, Sampangi R, et al.
Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization. [Journal Article]
Eur J Ophthalmol 2007 Jul-Aug; 17(4):620-6.
Abstract | Full Citation | | Haritoglou C, Kook D, Neubauer A, et al.
Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. [Journal Article, Research Support, Non-U.S. Gov't]
Retina 2006 Nov-Dec; 26(9):999-1005.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
